Hepatotoxicity after introduction of highly active antiretroviral therapy

被引:142
|
作者
Rodríguez-Rosado, R [1 ]
García-Samaniego, J [1 ]
Soriano, V [1 ]
机构
[1] Inst Salud Carlos III, Infect Dis Serv, Madrid, Spain
关键词
D O I
10.1097/00002030-199810000-00025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1256 / 1256
页数:1
相关论文
共 50 条
  • [1] Hepatotoxicity after introduction of highly active antiretroviral therapy (HAART) in HIV infected patients.
    Rodriguez-Rosado, R
    Garcia-Samaniego, J
    Perez-Olmeda, M
    Soriano, V
    Munoz, F
    Gonzalez-Lahoz, J
    [J]. HEPATOLOGY, 1998, 28 (04) : 434A - 434A
  • [2] Liver toxicity after the introduction of highly active antiretroviral therapy
    Lana, R
    Mendoza, JL
    Núñez, M
    Soriano, V
    González-Lahoz, J
    [J]. AIDS, 2000, 14 : S63 - S63
  • [3] Period of onset and lack of clinical manifestation of hepatotoxicity after commencing highly active antiretroviral therapy
    Ugiagbe, R. A.
    Ugiagbe, E. E.
    [J]. NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2012, 15 (01) : 63 - 67
  • [4] Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy
    Gebo, KA
    Diener-West, M
    Moore, RD
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (02): : 143 - 152
  • [5] Latent pneumocystis infection revealed after introduction of highly active antiretroviral therapy
    Borie, R
    Camuset, J
    Bodart, L
    Cadranel, J
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (01) : 69 - 72
  • [6] Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy
    Bonfanti, P
    Landonio, S
    Ricci, E
    Martinelli, C
    Fortuna, P
    Faggion, I
    Quirino, T
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (03): : 316 - 318
  • [7] Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy
    Núñez, M
    Lana, R
    Mendoza, JL
    Martín-Carbonero, L
    Soriano, V
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (05): : 426 - 431
  • [8] Hepatotoxicity associated with highly active antiretroviral therapy (HAART) in HIV/AIDS patients
    Dragovic, G
    Jevtovic, D
    [J]. DRUG SAFETY, 2005, 28 (10) : 951 - 952
  • [9] Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy
    Rapiti, E
    Porta, D
    Forastiere, F
    Fusco, D
    Perucci, CA
    [J]. EPIDEMIOLOGY, 2000, 11 (05) : 496 - 501
  • [10] Highly active antiretroviral therapy
    Di Perri, G
    Bonora, S
    Vento, S
    Allegranzi, B
    Concia, E
    [J]. LANCET, 1998, 351 (9108): : 1056 - 1056